• Griseofulvin: Mechanistic Leverage in Antifungal Research

  2026-08-24

  Griseofulvin is more than a conventional antifungal research reagent: it is a mechanistically informative microtubule associated inhibitor that can connect fungal cell biology, mitotic control, and aneugenicity profiling. This article outlines how translational researchers can use Griseofulvin to interrogate microtubule disruption, strengthen assay design, and improve the interpretability of antifungal discovery programs.

• Chloroquine in MrgprA3+ Itch Assays

  2026-08-24

  Use Chloroquine as a receptor-defined stimulus for MrgprA3+ sensory-neuron studies while keeping its lysosomal and autophagy effects analytically separate. This workflow connects chronic-dermatitis behavior, calcium imaging, and flux-aware cell assays with practical controls for concentration, timing, solvent, and toxicity.

• CXCR4 Theranostics in Lymphoma: Imaging and Therapy

  2026-08-23

  This review explains how CXCR4-targeted imaging and therapeutic ligands can connect lymphoma biology with patient-selective diagnosis and treatment. Its main contribution is a clinically oriented synthesis of PET, SPECT, radioligand, peptide, small-molecule, and antibody strategies, while highlighting physiological uptake and CXCR7 compensation as important translational constraints.

• Capillarisenol C and ER Stress-Driven Autophagy

  2026-08-22

  The reference study identifies capillarisenol C, a bisphenol isolated from Artemisia capillaris, as an inducer of cytotoxic autophagy in HepG2 and Huh7 liver cancer cells. Pharmacological and genetic experiments connect this phenotype to PERK–eIF2α and IRE1 activation, while rescue by 4-PBA supports a central role for endoplasmic reticulum stress.

• AMPK, JAK2/STAT3, and Obesity-Related Asthma

  2026-08-22

  A 2025 study links reduced AMPK activity with M1 macrophage polarization and airway inflammation in obesity-related asthma, identifying JAK2/STAT3 signaling as a closely associated mechanistic pathway. Its combined mouse and RAW264.7 macrophage models provide a useful framework for investigating metabolic control of pulmonary inflammation, while also highlighting important limits in translating pharmacological AMPK activation to clinical treatment.

• TRIM21–ERK1/2 Signaling in Pituitary Adenomas

  2026-08-21

  The reference study identifies TRIM21 as an E3 ligase that links K27-linked ubiquitination of ERK1/2 to enhanced MEK–ERK signaling, pituitary adenoma growth, and treatment resistance. Its combination of CRISPR screening, biochemical validation, animal studies, and NanoBiT-based drug screening nominates TRIM21 suppression—and compounds including Quisinostat—as a testable strategy rather than an established clinical treatment.

• Difloxacin HCl: Assay Design Beyond DNA Gyrase

  2026-08-20

  Difloxacin HCl is a quinolone antimicrobial antibiotic with applications spanning bacterial susceptibility testing and multidrug resistance research. This article adds a practical assay-design perspective, using mechanistic lessons from Plk1–p31comet biology to distinguish causal evidence from cross-domain analogy.

• How Cholesterol Hinders LNP Intracellular Trafficking

  2026-08-20

  A 2025 International Journal of Pharmaceutics study developed a sensitive imaging platform to follow nucleic acid-loaded lipid nanoparticles through endocytic compartments. Its findings indicate that excess cholesterol promotes peripheral early-endosome trapping, whereas DSPC can reduce this aggregation, providing a mechanistic formulation perspective on intracellular delivery efficiency.

• Diminazene Aceturate: From Parasites to ACE2

  2026-08-19

  Diminazene Aceturate is best understood not only as a trypanocidal research reagent, but also as a pharmacological probe for ACE2-linked mitochondrial biology. This article connects parasitic infection research with sepsis-induced cardiomyopathy, outlines evidence-aware workflows, and defines the translational boundaries that should guide future studies.

• Nanoparticle mRNA Delivery in Trastuzumab Resistance

  2026-08-19

  The reference study developed a tumor-microenvironment pH-responsive nanoparticle system for systemic PTEN mRNA delivery in trastuzumab-resistant breast cancer. Its central finding is that restoring PTEN expression can suppress persistently active PI3K/Akt signaling and improve the response to trastuzumab, while also illustrating the delivery barriers that determine whether an mRNA strategy is therapeutically useful.

• AZ505: Reading SMYD2 Inhibition in Fibrosis

  2026-08-18

  AZ505 is a substrate-competitive SMYD2 inhibitor for dissecting methylation, inflammatory signaling, and renal fibrosis. This article translates mechanistic evidence into a layered assay strategy for epigenetic regulation research and cancer biology research.

• Mavorixafor in WHIM Syndrome: Phase 3 Evidence

  2026-08-18

  The reference paper highlights how daily oral mavorixafor translates CXCR4 biology into a targeted treatment strategy for WHIM syndrome. In a placebo-controlled phase 3 study, the CXCR4 antagonist prolonged periods of adequate neutrophil and lymphocyte counts and reduced infections, while leaving important questions about long-term outcomes unresolved.

• Removing Pollen Interference in EEM Bioaerosol Detection

  2026-08-17

  Zhang and colleagues developed a fluorescence-spectral preprocessing and random forest workflow to reduce pollen interference during hazardous bioaerosol classification. Fast Fourier transform treatment improved classification accuracy to 89.24%, supporting more reliable discrimination of bacterial and toxin-related signals in complex airborne samples.

• Enhanced ECL Detection Kit: Western Blot Guide

  2026-08-17

  The Enhanced ECL detection kit supports sensitive HRP-based western blot chemiluminescence detection when weak protein bands or limited sample are important. It is intended for HRP-linked protein immunodetection and should not be treated as a universal substrate for non-HRP labels or as independent evidence of quantitative performance.

• Metformin Attenuates Vocal Fold Fibrosis via AMPK

  2026-08-16

  A 2025 study reports that metformin reduced collagen deposition and profibrotic marker expression in rabbit vocal fold injury and TGF-β1-stimulated fibroblast models. Its key contribution is linking these effects to AMPK activation and suppression of the TGF-β/Smad axis, providing a mechanistic basis for further preclinical investigation rather than clinical treatment conclusions.

8403 records 1/561 page Next 12345 下5页 Last page